Haemato AG (HAEK) — Cash Flow Reinvestment Rate
Latest as of December 2022:
0.17x
Haemato AG (HAEK) has a Cash Flow Reinvestment Rate of 0.17x as of December 2022, reinvesting €3.30 Million (capex €1.09 Million plus investments €-2.21 Million) from operating cash flow of €19.73 Million. Explore HAEK capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.17x
(Capex + Investments) / Operating CF
Total Reinvested
€3.30 Million
Capex + Investments
Operating Cash Flow
€19.73 Million
EUR
Capital Expenditures
€1.09 Million
EUR
Haemato AG Cash Flow Reinvestment Rate (2021–2022)
Historical reinvestment intensity for Haemato AG across 2 annual periods. Also explore HAEK total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Haemato AG (2021–2022)
Year-by-year capital reinvestment analysis for Haemato AG. For live market cap and broader valuation context, see HAEK company net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.17x | €3.30 Million | €19.73 Million | €1.09 Million | ▲ +523.3% |
| 2021 | 0.03x | €376.80K | €14.05 Million | €326.75K | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow